Even in generally good-prognosis cutaneous leiomyosarcoma, careful follow-up is necessary when tumor cells infiltrate the deep dermis.
Deep dermal invasion may warrant vigilant surveillance in cutaneous leiomyosarcoma; leaves open need for validated risk stratification.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Katsumi et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: